Comparison of infectious complications with BCMA-directed therapies in multiple myeloma
Abstract B-cell-maturation-antigen (BCMA)-directed therapies are highly active for multiple myeloma, but infections are emerging as a major challenge. In this retrospective, single-center analysis we evaluated infectious complications after BCMA-targeted chimeric-antigen-receptor T-cell therapy (CAR...
Tallennettuna:
| Päätekijät: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Publishing Group
2024-05-01
|
| Sarja: | Blood Cancer Journal |
| Linkit: | https://doi.org/10.1038/s41408-024-01043-5 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
